Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Genespire has raised €16M across 1 funding round from 1 investor, most recently a Series A round in Apr 2020. Based in Milan, Italy; founded 2020; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-04-29 | Series A | €16M |
| Sofinnova Partners |
| View deal → |
